175 related articles for article (PubMed ID: 36337899)
21. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
[TBL] [Abstract][Full Text] [Related]
22. [The association of growth differentiation factor 15 (GDF-15) level with extent of left atrial fibrosis in patients with nonvalvular atrial fibrillation].
Gizatulina TP; Martyanova LU; Petelina TI; Zueva EV; Shirokov NE; Kolunin GV; Belonogov DV; Gorbatenko EA
Kardiologiia; 2020 Oct; 60(9):22-29. PubMed ID: 33131471
[TBL] [Abstract][Full Text] [Related]
23. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation.
Benz AP; Aeschbacher S; Krisai P; Moschovitis G; Blum S; Meyre P; Blum MR; Rodondi N; Di Valentino M; Kobza R; De Perna ML; Bonati LH; Beer JH; Kühne M; Osswald S; Conen D;
J Am Heart Assoc; 2021 Apr; 10(8):e019168. PubMed ID: 33843247
[TBL] [Abstract][Full Text] [Related]
25. Impact of right atrial enlargement on clinical outcome in patients with atrial fibrillation.
Ko KY; Jang JH; Choi SH; Baek YS; Kwon SW; Park SD; Woo SI; Kim DH; Shin SH
Front Cardiovasc Med; 2022; 9():989012. PubMed ID: 36211539
[TBL] [Abstract][Full Text] [Related]
26. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.
Luo J; Xu S; Li H; Li Z; Liu B; Qin X; Gong M; Shi B; Wei Y
ESC Heart Fail; 2020 Oct; 7(5):2762-2772. PubMed ID: 32578394
[TBL] [Abstract][Full Text] [Related]
27. Temporal Relationship between Atrial Fibrillation and Heart Failure Development Analysis from a Nationwide Database.
Cottin Y; Maalem Ben Messaoud B; Monin A; Guilleminot P; Bisson A; Eicher JC; Bodin A; Herbert J; Juillière Y; Zeller M; Fauchier L
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768619
[TBL] [Abstract][Full Text] [Related]
28. Predictors of the paroxysmal atrial fibrillation recurrence following cryoballoon-based pulmonary vein isolation: Assessment of left atrial volume, left atrial volume index, galectin-3 level and neutrophil-to-lymphocyte ratio.
Celik AI; Kanadasi M; Demir M; Deniz A; Akilli RE; Deveci OS; Cagliyan CE; Ozmen C; Ikikardes F; Karaaslan MB
Indian Pacing Electrophysiol J; 2019; 19(1):9-14. PubMed ID: 30712532
[TBL] [Abstract][Full Text] [Related]
29. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.
Chatterjee NA; Chae CU; Kim E; Moorthy MV; Conen D; Sandhu RK; Cook NR; Lee IM; Albert CM
JACC Heart Fail; 2017 Aug; 5(8):552-560. PubMed ID: 28624486
[TBL] [Abstract][Full Text] [Related]
30. Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis.
Mendez IJ; Manemann SM; Bell EJ; Larson NB; Decker PA; Guerrero MA; Hanson NQ; Heckbert SR; Pankow JS; Tsai MY; Bielinski SJ
BMC Cardiovasc Disord; 2021 Sep; 21(1):436. PubMed ID: 34521347
[TBL] [Abstract][Full Text] [Related]
31. Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.
Zhou YM; Li MJ; Zhou YL; Ma LL; Yi X
Int J Clin Exp Med; 2015; 8(11):21201-7. PubMed ID: 26885055
[TBL] [Abstract][Full Text] [Related]
32. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
33. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.
Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N
Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370
[TBL] [Abstract][Full Text] [Related]
34. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
[TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation and mortality in outpatients with heart failure in Tanzania: a prospective cohort study.
Chen Y; Alphonce E; Mujuni E; Kisigo GA; Kingery JR; Makubi A; Peck RN; Kalokola F
BMJ Open; 2022 Jan; 12(1):e058200. PubMed ID: 35046009
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death.
Schrage B; Geelhoed B; Niiranen TJ; Gianfagna F; Vishram-Nielsen JKK; Costanzo S; Söderberg S; Ojeda FM; Vartiainen E; Donati MB; Magnussen C; Di Castelnuovo A; Camen S; Kontto J; Koenig W; Blankenberg S; de Gaetano G; Linneberg A; Jørgensen T; Zeller T; Kuulasmaa K; Tunstall-Pedoe H; Hughes M; Iacoviello L; Salomaa V; Schnabel RB
J Am Heart Assoc; 2020 May; 9(9):e015218. PubMed ID: 32351154
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of new-onset atrial fibrillation associated with worsening heart failure in aging patients with severely decompensated acute heart failure.
Kiuchi K; Shirakabe A; Kobayashi N; Okazaki H; Matsushita M; Shibata Y; Goda H; Shigihara S; Asano K; Tani K; Hata N; Asai K; Shimizu W
Int J Cardiol; 2020 Mar; 302():88-94. PubMed ID: 31813678
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation.
Koike T; Ejima K; Kataoka S; Yazaki K; Higuchi S; Kanai M; Yagishita D; Shoda M; Hagiwara N
Int J Cardiol Heart Vasc; 2022 Aug; 41():101079. PubMed ID: 35812132
[TBL] [Abstract][Full Text] [Related]
40. Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation.
Wang Q; Xu L; Dong Y; Fu Y; Pan Y; Luan Q; Liu Y; Liu Z; Yang X; Chen M; Gao Y
BMC Cardiovasc Disord; 2021 May; 21(1):226. PubMed ID: 33934700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
